Key Segments:
By Product Type
-
Devices
-
Software and Consumables
By Application
-
Drug Discovery
-
Genetic Research
-
Diagnostics
-
Targeted Drug Delivery
-
Others
By End User
-
Research Laboratories
-
Pharma and Biotech Companies
-
Hospitals and Clinics
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Switzerland
-
Italy
-
Spain
-
Rest of Europe
Asia Pacific
-
Japan
-
China
-
South Korea
-
India
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Israel
-
Saudi Arabia
-
UAE
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product Type X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes Danaher Corporation (Medical Devices LLC), Bruker, Thermo Fisher Scientific, Qiagen, Imina Technologies SA, and among others. These suppliers compete on imaging resolution, automation depth, and breadth of qualified research and biopharmaceutical applications.
The main opportunities lie in software-driven automation that lowers the specialized operator skill nanomanipulation instruments historically required, and in expansion into semiconductor and advanced-materials research, where fabrication and failure-analysis teams are adopting the same scanning probe and electron-beam platforms that life-science laboratories use.
The key growth factor is expanding drug discovery and gene-editing validation workloads, which require laboratories to confirm molecular-level outcomes at a resolution that standard screening assays and sequencing data cannot provide on their own.
By product type, the Devices segment dominated the market with approximately 61.00% share in 2025, supported by its role as the physical backbone of molecular-scale manipulation workflows. The Drug Discovery application and Research Laboratories end-user segments led their respective axes.
North America dominated the market with approximately 38.00% share in 2025, led by the United States and its concentration of research hospitals, national laboratories, and biopharmaceutical developers. Asia Pacific is the fastest-growing region, at a CAGR of approximately 19.2%.
